Skip to Main Content

517

Views

0

CrossRef citations to date

0

Altmetric

Original Research

A cost-effectiveness analysis of empagliflozin for heart failure patients across the full spectrum of ejection fraction in Spain: combined results of the EMPEROR-Preserved and EMPEROR-Reduced trials

Xavier García-Molla Cardiology Department, Santa Creu I Sant Pau University Hospital, Barcelona, SpainView further author information

,

Francesco Crocib EMEA Real World Methods & Evidence Generation, IQVIA, London, UKCorrespondence[email protected]
View further author information

,

Alexandra Soléc Market Access, Boehringer Ingelheim España S.A., Barcelona, SpainView further author information

,

Elisabeth S. Hartgers-Gubbelsd Corporate Market Access CardioRenalMetabolism, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, GermanyView further author information

&

Miguel A. Calleja-Hernándeze Servicio de Farmacia, Virgen Macarena University Hospital, Sevilla, SpainView further author information